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Introduction
Ghana is exhibiting impressive economic gains that may compare with the growth rates
expected in India or China. With economic development, there is an expectation that the prev-
alence and disease burden of the neglected tropical diseases (NTDs) and other poverty-related
neglected diseases will decline. Indeed, guinea worm, human African trypanosomiasis, and
trachoma recently have been eliminated in Ghana, and there have been steep declines in the
prevalence of onchocerciasis and lymphatic filariasis (as well as oesophogostomiasis and
yaws), with the prospect of eliminating these diseases as well in the not-too-distant future. In
contrast, progress toward disease prevalence reductions for schistosomiasis, hookworm, and
other soil-transmitted helminth infections, as well as other NTDs, including cysticercosis, cys-
tic echinococcosis, scabies, Buruli ulcer, and leprosy, have been more modest. Snake bite
envenoming, an important regional noninfectious NTD, also requires a different strategic
approach. Arbovirus infections are emerging and thus remain a significant and under-recog-
nized public health threat. For some of these NTDs, new technologies, including vaccines, will
be required. Health-system strengthening with mobile health-activities are expected to con-
tinue furthering NTD disease reductions, with the hope that Ghana could become the first
highly populated Sub-Saharan African nation to achieve its NTD elimination targets.
Overview
The Republic of Ghana occupies a land mass of 238,500 square kilometers with a rising popu-
lation now approaching 30 million people (Fig 1) [1]. Ghana is showing signs of impressive
economic growth. It is estimated that approximately one quarter (24.2%) of Ghanaians lived
below the national poverty line as of 2013, down from 56.5% in 1992 with reductions in urban
poverty achieving the greatest gains [2]. Indeed, recent accounts suggest that Ghana currently
boasts a relatively high annual growth rate [3], expected to be in the range of 5% to 9% per
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annum in coming years, roughly comparable to rates expected for China or India. For exam-
ple, the World Bank and the African Development Bank each estimate that Ghana’s economy
will accelerate to between 8% and 9% in 2018, with some decrease of the growth rate in subse-
quent years [3–5].
One of the most potent effects of rapid economic development and improvement is the
reduction in parasitic and related NTDs [6]. The exact mechanisms that inversely link rising
economies to NTDs remain to be fully understood, but the relationships represent important
late 20th century and early 21st century narratives [7]. For example, with the rapid economic
improvements in Eastern China over the last two decades, there have been steep declines in
helminth infections, whereas these diseases largely remain highly prevalent in China’s impov-
erished southwestern regions [7,8]. Aggressive economic improvements following World War
II in Japan and South Korea have also been linked to historic decreases in helminthiases and
other NTDs [7].
For these reasons, it is of interest to see if Ghana’s recent economic growth is translating
into public health gains through reductions in NTDs. Shown in Table 1 are results from the
Global Burden of Disease (GBD) Study 2017 that compare prevalence (parasitic and bacterial
NTDs) or incidence (dengue) rates of some of the major NTDs, both at the launch of the Mil-
lennium Development Goals (MDGs) and then in the year 2017 [9].
NTDs targeted for elimination
Among the most significant NTD progress in Ghana since the launch of the MDGs have been
the certified eliminations of guinea worm transmission and trachoma and the near elimination
of human African trypanosomiasis, as well as dramatic reductions in the prevalence and inten-
sity of onchocerciasis and lymphatic filariasis (LF). For each of these NTDs, however, it is diffi-
cult to attribute these public health successes directly to economic development instead of
concerted and targeted vertical intervention programs assisted by donor support.
Fig 1. The nation of the Republic of Ghana. Original figure made with mapchart.net.
https://doi.org/10.1371/journal.pntd.0007005.g001
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Ghana’s guinea worm eradication program was launched in 1988 as a partnership with the
Carter Center, UNICEF, and WHO [10]. Although almost 200,000 cases were initially reported
a year after the launch, through aggressive programs of providing access to safe water, chemi-
cal treatments against copepods, health education, case containment, establishment of a
reward system, and improved surveillance and reporting, the transmission of guinea worm
disease was halted in 2010, and the absence of transmission was certified by WHO in 2015
[10]. The progress leading to elimination was achieved despite a temporary setback due to eth-
nic conflicts in northern Ghana and an “epidemic” event in which water supplies were dis-
rupted in a major city and contaminated drinking water was supplied to the population
resulting in a surge of cases [10].
Similarly, the Carter Center’s Trachoma Control Program initiated work with the Ghana
Health Service to train community health workers and launch programs of health education
and sanitation, while implementing the SAFE (Surgery, Antibiotic mass treatment with azi-
thromycin, Face washing and Environmental improvement) strategy, such that by 2008 Ghana
became the first nation in Sub-Saharan Africa to meet critical elimination targets, with every
community with trachoma receiving SAFE interventions for three years or more [11, 12].
However, follow-up surveys indicated that trachoma, although greatly reduced, was still not
entirely eliminated, and efforts were required to pivot away from mass treatments in order to
focus on post-treatment surveillance and on case detection and treatment to eliminate the
backlog of trichiasis surgery [11, 12]. In subsequent years, the Ghana NTD Program in collab-
oration with the END in Africa project of FHI360, the International Trachoma Initiative of the
Task Force for Global Health, and Sightsavers International continued this approach, such
that in 2015 efforts were redoubled to push for true elimination [11–13]. From these activities,
it appears that trachoma has been eliminated, with Ghana becoming the first nation in the
WHO’s African region to reach this goal [14]. In addition, annual azithromycin treatments
appear to have some impact on reducing the prevalence of yaws in Ghana [15].
For both onchocerciasis and LF, significant reductions in the parasitological parameters of
prevalence (greater than 90% reduction) and intensity and entomological measures of trans-
mission have been achieved initially for onchocerciasis via larviciding and later through mass
drug administration (MDA) with ivermectin or ivermectin together with albendazole for lym-
phatic filariasis. In Ghana, the Onchocerciasis Control Program (OCP) began in 1974 through
vector control activities before switching to MDA in 1998 (with the exception of the Asubende
focus in which vector control continued under the OCP Special Intervention Zones) [16].
Table 1. Comparison of prevalence and incidence of selected NTDs in Ghana in the years 2000 and 2017 [9].
Parasitic and bacterial NTDs Estimated prevalence in 2000 Estimated prevalence in 2017 Percentage change 2000–2017
Hookworm 2,741,253 2,993,431 +09%
Schistosomiasis 1,416,722 968,264 -32%
Ascariasis 853,804 897,167 +05%
Lymphatic Filariasis 744,181 59,929 -92%
Trichuriasis 351,952 491,130 +40%
Onchocerciasis 91,456 5,987 -93%
Guinea worm 3,345 0 -100%
Leprosy 1,078 800 -26%
Viral NTDs Estimated incidence in 2000 Estimated incidence in 2017
Dengue 70,526 308,811 +338%
Abbreviation: NTD, neglected tropical disease.
https://doi.org/10.1371/journal.pntd.0007005.t001
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Following a mapping exercise that identified remaining endemic areas, starting in 2009, 85 of
the 216 districts in Ghana began to receive mass treatments. In 2006, the NTD Program of the
United States Agency for International Development (USAID) expanded support for oncho-
cerciasis and LF control through an integrated program of MDA, which also includes the soil-
transmitted helminthiases and schistosomiasis [17]. The program was led by the Ghana Health
Service, which was further supported in 2010 by END in Africa [16]. In some areas, ivermectin
is delivered twice a year in a biannual treatment strategy [18]. A significant concern, however,
is that as adult Onchocerca volvulus worms can live for more than a decade, so ongoing MDA
will be required for some years to come. In addition, a study in Ghana in which ivermectin
had been used for many years showed that there was an increase in the rate of repopulation of
the skin, suggesting that there was reduced efficacy of the drug [19]. However, according to
the GBD 2017, more than a 90% reduction has been achieved. A recent impact assessment
indicates that MDA has had significant effect such that control efforts for onchocerciasis can
transition toward an elimination strategy. In so doing, areas of the countries that became
“hypo-endemic” as a result of MDA are being retargeted. The GBD studies may not fully con-
sider those populations who remain afflicted by irreversible blindness and disfiguring skin dis-
ease—a situation, which is paralleled in cutaneous leishmaniasis; only active infections are
considered by the GBD metrics, excluding those with residual “inactive” disease [20].
LF is simultaneously targeted through ivermectin and albendazole MDA, resulting in sig-
nificant prevalence reductions such that mass treatment is no longer needed in many health
districts. LF control and elimination efforts first began during the late 1990s, following a
World Health Assembly resolution [21–24], and accelerated after an extensive mapping exer-
cise conducted jointly by the Ghana Health Service and the Liverpool School of Tropical Medi-
cine in 2001 [23] through support from the United Kingdom Department for International
Development. Overall, it is estimated that more than 13 million people in Ghana no longer
require MDA. However, a number of important LF “hotspots” remain and will continue to
require treatment [24, 25]. Some investigators consider that Ghana is on the verge of LF elimi-
nation in urban areas of Ghana and elsewhere in West Africa, so that MDA could be replaced
with case surveillance and treatment [26]. It has also been noted that the use of albendazole
and ivermectin in the LF and onchocerciasis programs has been attributed to the decline—and
possibly elimination—of a soil-transmitted helminth infection, oesophagostomiasis, which is
seemingly unique to northern Ghana and Togo [27–29].
In summary, the combined effects of economic development and MDA are leading to rapid
decreases in the prevalence and transmission of onchocerciasis, LF, oesophagostomiasis, and
yaws, whereas guinea worm infection and trachoma have already been eliminated in Ghana.
No cases of human African trypanosomiasis (a historic scourge) have been reported over
recent years, suggesting it has also been eliminated [30], possibly due to the expanding rural
population and increased pressure on available land resource resulting in the drastic decline in
Glossina palpalis tsetse habitats. Overall, if these trends and activities are sustained, there is
optimism that Ghana could lead countries of Sub-Saharan African in terms of NTD elimina-
tion efforts with success achieved sometime in the 2020s.
NTDs that remain widespread
In contrast to the public health successes highlighted above, for other high prevalence NTDs,
the gains appear to be more modest. According to the GBD 2017, schistosomiasis is the second
most prevalent human helminth infection (following hookworm infection) in Ghana, affecting
almost one million people [9]. Schistosoma haematobium, the cause of urogenital schistosomi-
asis is the predominant human schistosome, but Schistosoma mansoni, the cause of intestinal
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schistosomiasis, is also prevalent [31, 32]. The prevalence of schistosomiasis increased sharply
following the creation of Lake Volta after the construction of the Akosombo hydroelectric
dam during the 1960s [33]. Before 2007, schistosomiasis control relied primarily on snail con-
trol, especially in the basin of the Volta River [31]. In 2008, USAID began supporting programs
of MDA, which included mass treatments with praziquantel [34]. Disease mapping and MDA
programs have accelerated in the last five years for schistosomiasis (and also the major soil-
transmitted helminth infections) [31–35]. With respect to the former, impact assessments con-
ducted in 2016 show overall reductions in endemicity, although population increases in many
of the endemic areas have maintained or even increased estimates of the number of people
considered at risk for schistosomiasis. According to the GBD 2017, the overall prevalence of
schistosomiasis in Ghana has decreased by approximately one-third since 2000 [9]. Pending
significant declines in schistosomiasis prevalence, it is possible that a control strategy might be
switched to case detection using sensitive diagnostics and then treatment. Two additional
platyhelminth infections, cysticercosis and cystic echinococcosis, also remain endemic.
All three major soil-transmitted helminthiases—hookworm infection, ascariasis, and tri-
churiasis—are also widespread in Ghana, especially among pediatric populations. Whereas
MDA appears to have been effective at reducing the transmission of LF and onchocerciasis in
Ghana, the GBD 2017 suggests that this approach has not been as successful in diminishing
the prevalence of soil-transmitted helminth infections. However, given the extensive distribu-
tion of albendazole and ivermectin for LF and onchocerciasis programs over the last 20 years,
it would be expected that indeed both the prevalence and intensity of soil-transmitted hel-
minth infections may also be starting to decline. Of the three, hookworm infection is the pre-
dominant soil-transmitted helminth infection, both according to GBD 2016 and field based
investigative studies [36–38]. In Ghana, hookworm infection has been linked to serious mal-
nutrition among both children and adults, and it has been noted that endemic hookworm is
often refractory to single dose albendazole MDA [36–38]. Indeed, reduced albendazole suscep-
tibility among hookworm isolates in Ghana following treatment has suggested the possibility
of emerging albendazole drug resistance [37]. However, underlying nutritional status may also
be a factor in the varying levels of albendazole drug efficacies [38]. Also related to hookworm
and malnutrition is the high incidence and prevalence of hookworm and malaria coinfections,
leading to severe anemia [36–38]. Indeed, comorbidities from malaria and a wide range of
childhood infections are common [39].
Other NTDs that remain endemic include Buruli ulcer [40, 41]. During the early 2000s,
almost 6,000 patients were identified [40], although initiatives are underway to promote early
case detection and treatment through community-based surveillance volunteers [42]. Recent
application of geographic information systems has identified Buruli ulcer “hotspots” along spe-
cific riverine areas that might be targeted for enhanced surveillance and treatment [43]. Ghana
has been at the forefront of the development of a new WHO-approved treatment strategy for
buruli ulcer based on oral antibiotic therapy [44] as well as studies on the social and mental
health burden of this condition [45]. Leprosy also remains prevalent, although the numbers of
cases have dramatically declined since the introduction of multidrug therapy [46]. Additional
and important NTDs include scabies and snake-bite envenomation.
Finally, among the arbovirus infections, the incidence of dengue in Ghana and elsewhere in
West Africa is believed to have risen precipitously. Dengue risk appears to be the highest in
coastal areas [47]. One of the major issues affecting dengue in Ghana is the lack of disease sur-
veillance efforts, especially in febrile patients who are presumed to be infected with malaria
[47–49]. According to WHO, Ghana is one of 14 countries considered at high risk of yellow
fever outbreaks, although it is not currently one of the four West African nations considered as
a “complex emergency situation” [50].
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Future directions and call to action
The extent to which Ghana’s economic gains have translated or are directly related to reduc-
tions in NTD prevalence and incidence remains to be determined. Ghana has successfully
eliminated guinea worm and trachoma (certified by WHO) and is on a path to eliminate some
additional high profile NTDs such as yaws, onchocerciasis, and LF. The dramatic reduction in
urban poverty suggests that any urban foci of these diseases would be the first to disappear,
possibly even without MDA. However, across the rural areas of Ghana, schistosomiasis and
soil-transmitted helminthiases, especially hookworm infection, remains widespread, and den-
gue appears to be on the rise.
Ghana is on a good trajectory in terms of providing access to NTD essential medicines and
healthcare, with the recent adoption of mobile health (mhealth) practices and other innova-
tions that include several sectors of the economy. A road map is in place to scale-up successful
models that demonstrate adequate value. Going paperless is an important advance in the
health systems, with mhealth taking the lead in scalable technologies to support healthcare
delivery despite challenges associated with security, open sourcing, and appropriate software
design. Mhealth is currently being used to provide feedback on blood stocks and verbal autop-
sies as well as support the District Health Information Systems Version 2. Community health
workers (CHWs) are being deployed nationally to provide various primary health services and
increasingly are utilizing mhealth systems. In addition, over the last two decades, there has
been an impressive increase in human capacity dedicated to research on NTDs supported
from both within Ghana and via external contributions thereby strengthening individual and
institutional research programs on many of the NTDs together with the establishment of the
Secretariat of African Research Network for NTDs.
Based on past trajectories in several East Asian countries, in which MDA went hand-in-
hand with aggressive economic development, we should start to see steep declines in all of
Ghana’s NTDs, leading to elimination of some currently high-profile diseases. For schistoso-
miasis and soil-transmitted helminthiases, there is also some early progress, although an
expanding population in at-risk areas makes public health gains more problematic to assess.
The concerns about albendazole resistance and reduced ivermectin efficacy will also need to
be addressed, with consideration of developing improved biotechnologies for some of the
NTDs [51]. Moreover, we have seen how dengue and yellow fever can persist even in middle-
income countries, so that for these diseases as well new technologies will need to be developed
and implemented. With an appropriate focus on mhealth and community-based health ser-
vices, including the national deployment of CHWs supported by mhealth applications, Ghana
could become the first Sub-Saharan African nation with a large population to achieve wide-
spread success in NTD control and elimination. With targeted and scaled-up efforts, Ghana
has the potential to eliminate the major NTDs over the next decade.
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